Following the flow cytometry-gating strategy detailed in online supplemental figure S1A,1 we first defined that DNGR-1 expression was restricted to cDC1s among tumor myeloid infiltrates by monitoring the GFP fluorescence derived from the Clec9agfp/gfp knockin cassette (online supplemental figure S1B). The gene discussed is CLEC9A; the disease is neoplasm.